Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Eton Pharmaceuticals (ETON) Asset Utilization Ratio: 2020-2025

Historic Asset Utilization Ratio for Eton Pharmaceuticals (ETON) over the last 6 years, with Sep 2025 value amounting to 0.53.

  • Eton Pharmaceuticals' Asset Utilization Ratio fell 68.53% to 0.53 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.53, marking a year-over-year decrease of 68.53%. This contributed to the annual value of 0.72 for FY2024, which is 35.11% down from last year.
  • According to the latest figures from Q3 2025, Eton Pharmaceuticals' Asset Utilization Ratio is 0.53, which was up 15.67% from 0.46 recorded in Q2 2025.
  • Over the past 5 years, Eton Pharmaceuticals' Asset Utilization Ratio peaked at 1.82 during Q1 2024, and registered a low of 0.41 during Q1 2025.
  • Moreover, its 3-year median value for Asset Utilization Ratio was 1.05 (2023), whereas its average is 1.09.
  • Per our database at Business Quant, Eton Pharmaceuticals' Asset Utilization Ratio spiked by 5,397.33% in 2021 and then tumbled by 77.43% in 2025.
  • Over the past 5 years, Eton Pharmaceuticals' Asset Utilization Ratio (Quarterly) stood at 0.81 in 2021, then increased by 0.52% to 0.81 in 2022, then skyrocketed by 110.81% to 1.71 in 2023, then slumped by 59.28% to 0.70 in 2024, then plummeted by 68.53% to 0.53 in 2025.
  • Its Asset Utilization Ratio stands at 0.53 for Q3 2025, versus 0.46 for Q2 2025 and 0.41 for Q1 2025.